HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antibiotic treatment of chronic central venous hemodialysis catheter infection without catheter removal.

Abstract
Most catheter or shunt infections in hemodialysis patients require the removal of the access before the infection is eradicated. A hemodialysis patient is reported who had multiple previous vascular accesses which failed and thus who had very limited sites for future access placement. When a recurrent Proteus mirabilis catheter infection occurred, a 6-week course of ampicillin intraluminal and tobramycin systematically, eradicated the infection and thus the central venous catheter was salvaged. Serum bactericidal levels with these two antibiotics were obtained early in the course and supported the continued use of antibiotics alone to treat the infection.
AuthorsD T Domoto, D J Kennedy
JournalThe International journal of artificial organs (Int J Artif Organs) Vol. 10 Issue 4 Pg. 239-40 (Jul 1987) ISSN: 0391-3988 [Print] United States
PMID3312041 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Ampicillin
  • Tobramycin
Topics
  • Ampicillin (therapeutic use)
  • Catheterization, Central Venous (adverse effects)
  • Catheters, Indwelling (adverse effects)
  • Humans
  • Male
  • Middle Aged
  • Proteus Infections (drug therapy, microbiology)
  • Proteus mirabilis
  • Renal Dialysis (adverse effects)
  • Tobramycin (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: